Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Faggioni

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
NPJ Breast Cancer|November 26, 2025
Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumabGiorgio Bonomi, Gaia Griguolo, Tommaso Giarratano, et al.
Malaria Journal|February 16, 2017
Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals from Dschang, West CameroonGianluca Russo, Giovanni Faggioni, Giacomo Maria Paganotti, et al.
The Oncologist|April 21, 2026
Long-term outcome of isolated locoregional (ILRR) breast cancer (BC) recurrence: a large retrospective Mono-institutional studyGrazia Vernaci, Gaia Griguolo, Fabio Girardi, et al.
Journal of Women'S Health (2002)|July 3, 2018
Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer CenterMaria Vittoria Dieci, Cristina Ghiotto, Caterina Barbieri, et al.
Frontiers in Oncology|March 29, 2021
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA AnalysisLoredana Urso, Grazia Vernaci, Jessica Carlet, et al.
Current Oncology (Toronto, Ont.)|September 22, 2022
Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2- Advanced Breast Cancer Patients: An Italian Managed Access ProgramNicoletta Staropoli, Elena Geuna, Gaetana Rinaldi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 12, 2021
Identification and characterization of SARS-CoV-2 clusters in the EU/EEA in the first pandemic wave: additional elements to trace the route of the virusGiovanni Faggioni, Paola Stefanelli, Francesco Giordani, et al.
BMC Microbiology|April 8, 2006
Genotyping of Bacillus anthracis strains based on automated capillary 25-loci multiple locus variable-number tandem repeats analysisFlorigio Lista, Giovanni Faggioni, Samina Valjevac, et al.
Journal of Translational Medicine|April 19, 2015
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patientsMonica Benvenuto, Pierpaolo Sileri, Piero Rossi, et al.
The Oncologist|September 12, 2023
The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center in ItalyFabio Girardi, Sabrina Marini, Francesca Porra, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
NPJ Breast Cancer|November 26, 2025
Real-world outcomes of early-stage HER2-positive breast cancer patients treated with adjuvant paclitaxel and trastuzumabGiorgio Bonomi, Gaia Griguolo, Tommaso Giarratano, et al.
Malaria Journal|February 16, 2017
Molecular evidence of Plasmodium vivax infection in Duffy negative symptomatic individuals from Dschang, West CameroonGianluca Russo, Giovanni Faggioni, Giacomo Maria Paganotti, et al.
The Oncologist|April 21, 2026
Long-term outcome of isolated locoregional (ILRR) breast cancer (BC) recurrence: a large retrospective Mono-institutional studyGrazia Vernaci, Gaia Griguolo, Fabio Girardi, et al.
Journal of Women'S Health (2002)|July 3, 2018
Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer CenterMaria Vittoria Dieci, Cristina Ghiotto, Caterina Barbieri, et al.
Frontiers in Oncology|March 29, 2021
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA AnalysisLoredana Urso, Grazia Vernaci, Jessica Carlet, et al.
Current Oncology (Toronto, Ont.)|September 22, 2022
Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2- Advanced Breast Cancer Patients: An Italian Managed Access ProgramNicoletta Staropoli, Elena Geuna, Gaetana Rinaldi, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|October 12, 2021
Identification and characterization of SARS-CoV-2 clusters in the EU/EEA in the first pandemic wave: additional elements to trace the route of the virusGiovanni Faggioni, Paola Stefanelli, Francesco Giordani, et al.
BMC Microbiology|April 8, 2006
Genotyping of Bacillus anthracis strains based on automated capillary 25-loci multiple locus variable-number tandem repeats analysisFlorigio Lista, Giovanni Faggioni, Samina Valjevac, et al.
Journal of Translational Medicine|April 19, 2015
Natural humoral immune response to ribosomal P0 protein in colorectal cancer patientsMonica Benvenuto, Pierpaolo Sileri, Piero Rossi, et al.
The Oncologist|September 12, 2023
The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center in ItalyFabio Girardi, Sabrina Marini, Francesca Porra, et al.
Pageof 5